Bank of America
UTMD icon

Bank of America’s Utah Medical Products UTMD Stock Holding History

Bank of America’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$296K Buy
4,773
+2,056
+76% +$130K ﹤0.01% 5163
2025
Q4 		$152K Buy
2,717
+1,120
+70% +$64.9K ﹤0.01% 5463
2025
Q3 		$101K Sell
1,597
-195
-11% -$11.5K ﹤0.01% 6593
2025
Q2 		$102K Sell
1,792
-416
-19% -$22.6K ﹤0.01% 6513
2025
Q1 		$124K Sell
2,208
-2,720
-55% -$163K ﹤0.01% 6399
2024
Q4 		$303K Buy
4,928
+795
+19% +$51.4K ﹤0.01% 5879
2024
Q3 		$277K Buy
4,133
+600
+17% +$40.7K ﹤0.01% 5854
2024
Q2 		$236K Buy
3,533
+1,851
+110% +$126K ﹤0.01% 5802
2024
Q1 		$120K Sell
1,682
-1,847
-52% -$139K ﹤0.01% 6158
2023
Q4 		$297K Buy
3,529
+396
+13% +$32.8K ﹤0.01% 5841
2023
Q3 		$269K Buy
3,133
+2,236
+249% +$206K ﹤0.01% 5725
2023
Q2 		$83.6K Sell
897
-721
-45% -$67.9K ﹤0.01% 6269
2023
Q1 		$153K Sell
1,618
-479
-23% -$44K ﹤0.01% 6053
2022
Q4 		$211K Buy
2,097
+1,597
+319% +$146K ﹤0.01% 5882
2022
Q3 		$43K Sell
500
-1,627
-76% -$144K ﹤0.01% 6744
2022
Q2 		$183K Sell
2,127
-3,085
-59% -$263K ﹤0.01% 6155
2022
Q1 		$468K Buy
5,212
+2,360
+83% +$217K ﹤0.01% 5884
2021
Q4 		$285K Buy
2,852
+1,412
+98% +$144K ﹤0.01% 6279
2021
Q3 		$134K Sell
1,440
-70
-5% -$6.18K ﹤0.01% 6556
2021
Q2 		$128K Sell
1,510
-1,682
-53% -$146K ﹤0.01% 6373
2021
Q1 		$277K Buy
3,192
+1,615
+102% +$142K ﹤0.01% 5800
2020
Q4 		$133K Buy
1,577
+750
+91% +$63.9K ﹤0.01% 5837
2020
Q3 		$66K Sell
827
-752
-48% -$62.4K ﹤0.01% 5891
2020
Q2 		$139K Buy
1,579
+568
+56% +$51K ﹤0.01% 5492
2020
Q1 		$95K Sell
1,011
-418
-29% -$38.8K ﹤0.01% 5553
2019
Q4 		$154K Sell
1,429
-104
-7% -$10.5K ﹤0.01% 5781
2019
Q3 		$147K Buy
1,533
+175
+13% +$16.3K ﹤0.01% 5850
2019
Q2 		$129K Sell
1,358
-3,065
-69% -$258K ﹤0.01% 5868
2019
Q1 		$390K Buy
4,423
+2,233
+102% +$196K ﹤0.01% 5170
2018
Q4 		$182K Buy
2,190
+1,247
+132% +$110K ﹤0.01% 5580
2018
Q3 		$89K Sell
943
-7,027
-88% -$671K ﹤0.01% 5930
2018
Q2 		$877K Buy
7,970
+4,661
+141% +$487K ﹤0.01% 4560
2018
Q1 		$327K Buy
3,309
+2,881
+673% +$257K ﹤0.01% 5097
2017
Q4 		$35K Buy
428
+187
+78% +$14.6K ﹤0.01% 6216
2017
Q3 		$18K Buy
241
+237
+5,925% +$17K ﹤0.01% 6322
2017
Q2 		$0 Sell
4
-663
-99% -$43.6K ﹤0.01% 7182
2017
Q1 		$42K Sell
667
-5,205
-89% -$328K ﹤0.01% 6008
2016
Q4 		$427K Buy
5,872
+5,718
+3,713% +$372K ﹤0.01% 4910
2016
Q3 		$9K Sell
154
-175
-53% -$11.1K ﹤0.01% 6434
2016
Q2 		$21K Buy
329
+229
+229% +$14.8K ﹤0.01% 6233
2016
Q1 		$6K Sell
100
-90
-47% -$5.31K ﹤0.01% 6534
2015
Q4 		$11K Buy
190
+178
+1,483% +$10.1K ﹤0.01% 6646
2015
Q3 		$1K Sell
12
-241
-95% -$13.1K ﹤0.01% 7056
2015
Q2 		$15K Buy
253
+241
+2,008% +$13.6K ﹤0.01% 6455
2015
Q1 		$1K Buy
+12
New +$705 ﹤0.01% 6853
2014
Q4 		– Sell
-54
Closed -$3K – 7985
2014
Q3 		$3K Buy
+54
New +$2.74K ﹤0.01% 7705
2014
Q2 		– Sell
-23
Closed -$1K – 8223
2014
Q1 		$1K Buy
23
+7
+44% +$382 ﹤0.01% 7651
2013
Q4 		$1K Sell
16
-8
-33% -$439 ﹤0.01% 7748
2013
Q3 		$1K Sell
24
-1,013
-98% -$55.3K ﹤0.01% 7755
2013
Q2 		$56K Buy
+1,037
New +$48.8K ﹤0.01% 6491

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America's UTMD Position: Q1 2026 in Review

Bank of America increased its Utah Medical Products (UTMD) stake by 76% in Q1 2026, buying an estimated $130K and bringing the position to 4,773 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #5163.

Bank of America first reported a position in UTMD in Q2 2013 and has held it in 50 quarters since. The position peaked at $877K in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Bank of America held 4,773 shares of Utah Medical Products worth $296K as of Q1 2026.
  • Bank of America bought 2,056 Utah Medical Products shares in Q1 2026, an estimated $130K.
  • Utah Medical Products made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5163 holding.
  • Bank of America first reported a position in Utah Medical Products in Q2 2013 and has held it in 50 quarters since.
  • Bank of America's Utah Medical Products position peaked at $877K in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.